What is the MEOSUC-GLU-VAL-LYS-MET-PNA?

MEOSUC-GLU-VAL-LYS-MET-PNA is , while it's Molecular Formula is C 32 H 49 N 7 O 11 S. Used in Pharmaceutical Development: MEOSUC-GLU-VAL-LYS-MET-PNA is used as a building block for the development of targeted drug delivery systems. Its specific binding capabilities allow for the precise targeting of therapeutic agents to particular cells or tissues, enhancing the efficacy and reducing the side effects of treatments. Used in Peptide-based Therapeutics: MEOSUC-GLU-VAL-LYS-MET-PNA is utilized as a component in the creation of peptide-based therapeutics. The peptide's unique sequence and conjugation can be harnessed to develop new drugs that can modulate biological processes at the molecular level, offering innovative treatment options for various diseases. Used in Biomedical Research: MEOSUC-GLU-VAL-LYS-MET-PNA serves as a valuable tool in biomedical research. Its ability to bind specifically to target molecules and receptors makes it useful for studying the interactions between drugs and biological systems, as well as for the development of new diagnostic and therapeutic approaches. Used in Drug Delivery Systems: In the field of drug delivery, MEOSUC-GLU-VAL-LYS-MET-PNA is used as a targeting moiety for enhancing the specificity and efficiency of drug delivery. This can lead to improved therapeutic outcomes and reduced side effects by ensuring that drugs reach their intended targets more effectively. Used in Bioconjugation: MEOSUC-GLU-VAL-LYS-MET-PNA is used as a bioconjugation agent to attach drugs, imaging agents, or other molecules to specific biological targets. This can facilitate the development of conjugated systems with enhanced functionality, such as targeted drug delivery or biosensing applications. Used in the Development of Novel Pharmaceuticals: MEOSUC-GLU-VAL-LYS-MET-PNA is employed as a key component in the design and synthesis of novel pharmaceuticals. Its unique properties and sequence can be leveraged to create new drugs with improved targeting, efficacy, and safety profiles.

What is the CAS number for MEOSUC-GLU-VAL-LYS-MET-PNA?

The CAS number of MEOSUC-GLU-VAL-LYS-MET-PNA is 138486-85-8.

What is MEOSUC-GLU-VAL-LYS-MET-PNA (138486-85-8) used for?

MEOSUC-GLU-VAL-LYS-MET-PNA is a peptide that consists of the amino acid sequence methionine, glutamic acid, valine, lysine, and methionine conjugated to 2-methoxyethoxysuccinyl (MEOSUC). This chemical compound is notable for its potential applications in targeted drug delivery systems and peptide-based therapeutics, owing to its ability to specifically bind to target molecules and receptors in biological systems. The unique sequence and conjugation of MEOSUC-GLU-VAL-LYS-MET-PNA make it a promising candidate for the design of novel pharmaceuticals and biomedical research tools.

What is the MEOSUC-GLU-VAL-LYS-MET-PNA?

MEOSUC-GLU-VAL-LYS-MET-PNA is , while it's Molecular Formula is C 32 H 49 N 7 O 11 S. Used in Pharmaceutical Development: MEOSUC-GLU-VAL-LYS-MET-PNA is used as a building block for the development of targeted drug delivery systems. Its specific binding capabilities allow for the precise targeting of therapeutic agents to particular cells or tissues, enhancing the efficacy and reducing the side effects of treatments. Used in Peptide-based Therapeutics: MEOSUC-GLU-VAL-LYS-MET-PNA is utilized as a component in the creation of peptide-based therapeutics. The peptide's unique sequence and conjugation can be harnessed to develop new drugs that can modulate biological processes at the molecular level, offering innovative treatment options for various diseases. Used in Biomedical Research: MEOSUC-GLU-VAL-LYS-MET-PNA serves as a valuable tool in biomedical research. Its ability to bind specifically to target molecules and receptors makes it useful for studying the interactions between drugs and biological systems, as well as for the development of new diagnostic and therapeutic approaches. Used in Drug Delivery Systems: In the field of drug delivery, MEOSUC-GLU-VAL-LYS-MET-PNA is used as a targeting moiety for enhancing the specificity and efficiency of drug delivery. This can lead to improved therapeutic outcomes and reduced side effects by ensuring that drugs reach their intended targets more effectively. Used in Bioconjugation: MEOSUC-GLU-VAL-LYS-MET-PNA is used as a bioconjugation agent to attach drugs, imaging agents, or other molecules to specific biological targets. This can facilitate the development of conjugated systems with enhanced functionality, such as targeted drug delivery or biosensing applications. Used in the Development of Novel Pharmaceuticals: MEOSUC-GLU-VAL-LYS-MET-PNA is employed as a key component in the design and synthesis of novel pharmaceuticals. Its unique properties and sequence can be leveraged to create new drugs with improved targeting, efficacy, and safety profiles.

What is the CAS number for MEOSUC-GLU-VAL-LYS-MET-PNA?

The CAS number of MEOSUC-GLU-VAL-LYS-MET-PNA is 138486-85-8.

What is MEOSUC-GLU-VAL-LYS-MET-PNA (138486-85-8) used for?

MEOSUC-GLU-VAL-LYS-MET-PNA is a peptide that consists of the amino acid sequence methionine, glutamic acid, valine, lysine, and methionine conjugated to 2-methoxyethoxysuccinyl (MEOSUC). This chemical compound is notable for its potential applications in targeted drug delivery systems and peptide-based therapeutics, owing to its ability to specifically bind to target molecules and receptors in biological systems. The unique sequence and conjugation of MEOSUC-GLU-VAL-LYS-MET-PNA make it a promising candidate for the design of novel pharmaceuticals and biomedical research tools.

Cost-effective and customizable MeOSuc-Glu-Val-Lys-Met-pNA 138486-85-8 supplier

CAS#138486-85-8
NameMeOSuc-Glu-Val-Lys-Met-pNA
For reserach use only and not for human use!

Product Details

MF： C32H49N7O11S